Success Story: NIW Greenlight for Colombian Researcher - Approved Swiftly with Our Expert Help
Client’s Testimonial:
“Thank you so much for the service. I’m very satisfied with the process and the results.”
On March 24th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Research Assistant in the Field of Economics (Approval Notice).
General Field: Economics
Position at the Time of Case Filing: Research Assistant
Country of Origin: Colombia
State of Residence at the Time of Filing: District of Columbia
Approval Notice Date: March 24th, 2025
Processing Time: 1 month, 20 days (Premium Processing Requested)
Case Summary:
We are pleased to share the success story of an economist whose I-140 NIW (National Interest Waiver) petition was approved in just 1 month and 20 days under premium processing. This swift approval highlights the growing recognition of research at the intersection of artificial intelligence and health economics, and its significance in addressing critical issues such as healthcare affordability and equitable drug access.
The client holds a Master of Public Administration (M.P.A.) and is currently employed in the research sector, with plans to take on a consulting role in global development. His proposed endeavor focuses on designing advanced AI frameworks and data-driven policy models that guide the ethical implementation of AI-powered market intelligence in the healthcare and pharmaceutical sectors. By optimizing drug pricing mechanisms and improving healthcare accessibility, his work contributes directly to improving patient outcomes and reducing healthcare disparities.
Filed under the EB-2 NIW category, the petition featured:
● 4 peer-reviewed journal articles,
● 2 preprints, and
● 1 book publication,
● With a total of 84 citations according to Google Scholar.
To demonstrate the impact of his work, the petition highlighted the client’s widely cited research on pharmaceutical policy reforms and contraceptive access. His findings have not only informed academic discussions but have also been incorporated into health policy strategies by governmental bodies and international organizations.
In addition, the client’s work has influenced regulatory practices in countries aiming to improve access to essential medications. His models have guided policies that balance drug pricing with accessibility and have been used to strengthen monitoring systems designed to prevent unintended effects of price control mechanisms. His expertise in deploying AI tools for health market analysis positions him as a leader in shaping future frameworks for healthcare equity and affordability.
To further support the petition, two letters of recommendation were provided by leading experts in the fields of public health and economic development. These letters confirmed the national relevance and exceptional quality of the client’s research.
“[Client’s] results indicated that strong market monitoring and price interventions must be implemented in the Colombian pharmaceutical industry, which highlights how his research contributes to more efficient policies to reduce costs and maintain access to essential medications within the United States.”
With a carefully constructed petition that demonstrated the merit, national importance, and feasibility of the proposed endeavor, NAILG successfully secured this favorable result. We are proud to have supported this client and look forward to his continued contributions to economic innovation, digital policy, and AI-driven healthcare reform in the United States.